Apimeds Pharmaceuticals US, Inc.

Pharmaceutical company · Matawan, New Jersey, United States · NYSE: APUS

Apimeds Pharmaceuticals US, Inc. is a pharmaceutical company headquartered in Matawan, New Jersey, United States. Its shares trade on NYSE under the ticker APUS.

Profile compiled from public records. Is this your company? Request a correction or update

Apimeds Pharmaceuticals US at a glance

Typepharmaceutical company

HeadquartersMatawan, New Jersey, United States

Stock listingNYSE: APUS

SEC industryPharmaceutical Preparations

SEC CIK1894525

Frequently asked questions about Apimeds Pharmaceuticals US

Where is Apimeds Pharmaceuticals US headquartered?

Apimeds Pharmaceuticals US, Inc. is headquartered in Matawan, New Jersey, United States.

What does Apimeds Pharmaceuticals US do?

Apimeds Pharmaceuticals US, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Apimeds Pharmaceuticals US a public company?

Yes. Apimeds Pharmaceuticals US, Inc. trades on NYSE under the ticker APUS.

Similar companies

AbbVie Inc.North Chicago, Illinois, United States
Savara IncAustin, Texas, United States
Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Cartesian Therapeutics, Inc.Frederick, Maryland, United States
Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
Dare Bioscience, Inc.San Diego, California, United States
Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
Marker Therapeutics, Inc.Houston, Texas, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences